Related content

Electrochemotherapy Treatment of Locally Advanced and Metastatic Soft Tissue Sarcomas: Results of a Non-Comparative Phase II Study

By Campana Luca   Bianchi Giuseppe   Mocellin Simone   Valpione Sara   Campanacci Laura   Brunello Antonella   Donati Davide   Sieni Elisabetta   Rossi Carlo  

World Journal of Surgery, Vol. 38, Iss. 4, 2014-04 ,pp. : 813-822

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235) 1

By Kucuk O.   Fisher E.   Moinpour C.M.   Coleman D.   Hussain M.H.A.   Sartor A.O.   Chatta G.S.   Lowe B.A.   Eisenberger M.A.   Crawford E.D.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Five-year results of a phase II study with low-dose bacille calmette-guerin therapy in high-risk superficial bladder cancer

By Mack D.   Frick J.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 958-961

Elsevier

Access to resources Recommend Favorite

Phase II study of docetaxel and estramustine in metastatic androgen-independent prostate cancer

By Guimaraes T.   Bento M.J.   Pinho T.   Guedes d.C.R.   Pinto F.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 159-159

Elsevier

Access to resources Recommend Favorite

Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial

By Otto T.   Krege S.   Suhr J.   Rubben H.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite